Category: News and Announcements
Media Release: Global Health extends its Victorian Community Health Regional Network with signing of Ballarat Community Health
Australian Healthcare Software provider Global Health Limited (ASX: GLH) (“Global Health” or “Company”) is pleased to announce the signing of Ballarat Community Health, with a committed services and licensing revenue of $370,000 for the first year.
• Implementation of MasterCare EMR (Electronic Medical Record), MasterCare+, ReferralNet Secure Message Delivery and Dashboards-as-a-Service
• Combined $370,000 in revenue over the initial year of contract
• Over 200 new users on the MasterCare platform.
In commenting on this further regional development in Ballarat, Managing Director of Global Health, Mathew Cherian said:
“The ability of Global Health’s software solutions to meet the reporting requirements of State and Federal Government funded programs is proving to be the key factor in our growing adoption across Victorian Community Health. The solution stands out for its complete suite of clinical and client management modules that give clinicians access to market-leading tools at the point-of-care while reducing their administrative overheads.”
This contract will see Ballarat Community Health use Global Health’s MasterCare Platform to meet key reporting requirements for the NDIS, HACC, CHSP, VADC and now VINAH programs.
Growing adoption across the Victorian Community Health Network
Ballarat Community Health are the newest name to join Global Health’s growing Victorian Community Health Network in the 2020 financial year.
This … Read More »
XTEK Limited (ASX: XTE) (XTEK) and Skykraft Pty Ltd (Skykraft) are pleased to announce the award of an Australian Space Agency (ASA) Grant for the development of a SmallSats constellation launch stack.
• Skykraft, in conjunction with XTEK, awarded ASA International Space Investment grant to design and qualify a small satellite launch stack
• Follows Memorandum of Understanding signed with Skykraft for the co-engineering and potential manufacture of small spacecraft and launcher systems, first announced 12 June 2019
• XTEK’s advanced composite materials manufactured using its XTclave™ technology have unique technical advantages in space applications
• Validation of XTEK’s unique capabilities, with the collaboration providing a valuable opportunity to commercialise the XTclave™ technology and increasing XTEK’s presence in the space sector
Skykraft, in conjunction with project partner XTEK, have been awarded the Australian Space Agency’s International Space Investment: Expand Capability grant that will fully fund the design and qualify a launch stack system that deploys constellations of up to 30 SmallSats into low earth orbit from low cost rockets. The launch certification and validation will be carried out in collaboration with New Space India Limited who are the commercial provider of India’s Small Satellite Launch Vehicle (SSLV).
The award of this grant through XTEK’s partnership … Read More »
Media Release: Global Health Ltd Set To Deliver Stellar Results & Capitalises On COVID-19 Environment
Expected FY20 Financial
Highlights (Subject to audit)
Revenue up 12%Positive EBITDA Borrowings reduced by 45% to $600KNew Contracts for FY21 delivery up 50% on
Global Health Limited (ASX:
GLH) (“Global Health” or “Company”)
is pleased to provide its Business Update for the Financial Year
2019-2020, the impact of COVID on operations and the forward outlook.
Whilst the impact of COVID-19
has been unprecedented in terms of its economic and social impact in Australia,
and indeed throughout the world, Global Health has successfully adjusted and
navigated through these changed conditions.
Global Health staff have
adapted seamlessly to a remote working environment as the Company’s
infrastructure had been optimised for support of remote workforces prior to the
pandemic. Over 90% of our staff have been successfully working at home since
March 17th and have continued customer support, product development
and business development activities through the COVID-19 disruption.
Our staff have maintained a
high level of support for all our platforms and responded quickly to our
customers’ needs. This change in the work environment will continue until the
public health regulations of the Victorian Government are relaxed. A major
benefit to Global Health and its staff has been establishing a flexible work
environment which will likely continue into the post lockdown future.
Several projects that were
due to be delivered this financial year have … Read More »
XTEK Limited (ASX: XTE) (‘XTEK’ & ‘Company’) is pleased to advise that it has secured a A$2.5m loan
facility from the Commonwealth Bank of
Australia (CBA). This loan will be used to invest into the equipment for
the mass production of XTEK’s XTclave™ ballistic helmets.
secured A$2.5m loan facility with the Commonwealth Bank of AustraliaFunds to
be used primarily to enhance XTclaveTM ballistic helmet manufacturing line
within XTEK’s state-of-the-art manufacturing facility in AdelaideSuch
investment places XTEK in a stronger position to deliver on large commercial
orders for XTclaveTM ballistic helmetsGood
progress has been made with international customers and the first commercial
order for XTclaveTM ballistic helmets is expected in the near term
XTEK Managing Director, Philippe Odouard, said:
“This CBA loan facility
represents non-dilutive funding and is a step in optimising XTEK’s capital
structure. The funds will be used to design, build and install new
state-of-the-art equipment into the ballistic helmet manufacturing line in the
Adelaide manufacturing facility.
“This upgrade enhances our helmet
manufacturing capabilities and ensures XTEK is well positioned to deliver on
large quantities of our rifle ballistic helmets into the world’s biggest
markets. This helmet uniquely protects against AK47 rounds using an ultra-light
Polyethylene (PE) material.
“Significant progress has been
made with international customers recently, and we are working towards
finalising the first helmet order in the near term. … Read More »
Media Release: Skin Elements’ Natural Plant Based SE FormulaTM Successfully Tests Against Feline Coronavirus, a Surrogate of Coronavirus COVID-19
Elements’ Natural Plant Based SE FormulaTM Successfully Tests
Against Feline Coronavirus, a Surrogate of Coronavirus COVID-19
Independent laboratory testing of the SE
demonstrates 99.99% effectiveness against Feline Coronavirus, a surrogate of
Established Australian natural
skin care company Skin Elements Limited (ASX: SKN) (“Skin
Elements”, “the Company”), is pleased to advise that its SE FormulaTM,
a plant based active formulation has received the results from independent
laboratory testing which demonstrates 99.99% effectiveness against Feline
coronavirus, a surrogate of Coronavirus COVID-19.
Skin Elements has utilised its
expertise in developing advanced anti-microbial natural skincare formulations
to produce the SE Formula TM, which is an alcohol free
all-natural formulation incorporating
natural plant based extracts designed to deliver maximum protection whilst
addressing increasing concerns about skin sensitivity due to the high
repetitive use of alcohol-based sanitisers.
The independent test results for the
SE Formula TM demonstrated a 4-log reduction (99.99% effectiveness). This means that 99.99% of the virus is killed
after exposure to the SE Formula TM.
Log reduction is a common
logarithm measure of how thoroughly a decontamination process reduces the concentration
of a contaminant.
In general, an n-log reduction means that the concentration of remaining
contaminants is only 10−n times that of the original. So for
example, a 0-log reduction is no reduction at all, while a 1-log reduction
corresponds to a reduction of 90% … Read More »
Media Release: Hydrix Designs & Engineers Technologies Which Enhance People’s Health, Safety & Wellbeing
Guardian System is the world’s first FDA approved implantable heart attack
alert system using patented AI & Machine learning algorithms.
Australian product design & engineering company Hydrix Limited (ASX: HYD) (“Hydrix” or “Company”) has been helping technology companies to commercialise innovative products in the medical devices, consumer, industrial, mining and defence space for around 20 years.
Based out of
their state-of-the-art facility in Mulgrave, Victoria, Hydrix partners with
companies to help design, develop and commercialise their transformative
technologies which enhance people’s health, safety and wellbeing. Hydrix
provides clients with world class product engineering know-how to de-risk
product development, create market-leading solutions and accelerate go to
market strategies. The Company is leveraging this expertise into IP and product
ownership to generate long-term recurring product revenues.
Hydrix has created
ground-breaking solutions for clients operating in three large and growing
sectors – Medical Technology, Consumer & Industrials, and Defence & Rail. The Company is leveraging 1,000s of years of technology
commercialisation experience and know-how to capture more of the value it creates
through its Buy, Build & Invest strategy. One key example of this strategy
is Hydrix’s partnership with Angel
Medical Systems, Inc (AngelMed). Hydrixentered into a services agreement to assist in the development of
product upgrades of the Guardian® System (Guardian) device, entered
into an exclusive distribution agreement for parts … Read More »
A Win for Consumers, a Win for the Retailers and a Win for the Economy!
A new money-saving app is saving Australian consumers and
businesses. The ineda app was designed to create a ‘peoples market’ to help
Australian consumers save hundreds and thousands on appliances, insurance,
utilities and white goods, with plenty more on the app, and to help businesses
stay in business.
The free ineda app is
unique in the way it transparently facilitates consumers and retailers in a
reverse auction across numerous categories. The consumer may feel they are not
getting the best deal online or in store, so they will ‘post’ on the ineda app
for the goods they are after, a fridge or a washing machine for example. The
consumer will then receive numerous bids from local and interstate retailers,
‘some big names and some small operators’ with lower prices than advertised
online or in store. The consumer is then able to select the lowest price from
the retailer they choose, and organise for the delivery of their new fridge or
washing machine the next day. How good is that? It’s a win, win, win! A
win for the consumer, a win for the retailer and a win for the economy!
While isolation thanks to COVID-19 may be good for our
health, it is … Read More »
Media Release: Avenue Capital Managers Launches Unique Retail Petroleum Fund To Initially Raise $7.65 Million
Avenue Capital Managers, in conjunction with CoBrand Group, Nexia Melbourne, Guildfords Funds Management, and Bourse Communications, are pleased to announce the launch of the Retail Petroleum Fund (“RPF” or “the Fund”).
Retail Petroleum Fund’s vision is to become an
Australian leader in the ownership of retail fuel sites. This will be achieved
by establishing a revenue stream of long term rental returns from nationally
and globally positioned major anchor tenants and the ability to grow
stakeholder wealth through building scale both within and across the retail
The current offering in Stage One is to raise up to $7.65
million. Further raisings for the Fund will follow.
The Fund is an open-ended unlisted unregistered
wholesale managed investment scheme structured as a unit trust established by
the Trustee pursuant to the Trust Deed and is governed by Australian law. The Fund aims to achieve a 10% return on equity per annum.
Ownership of Australian retail fuel sites across the country
is at the beginning of a major paradigm shift that is already being witnessed
around the globe. Over the past few years, the Australian retail fuel industry
has undergone significant transformational change with new competition entering
the market. As a result, the industry has experienced strong levels of growth,
expanding at 2.4% annually.
The current strategy … Read More »
XTEK Limited (ASX: XTE) (‘XTEK’ & ‘Company’) is pleased to advise that it has received the first international commercial order for its light weight XTclave™ manufactured ballistic plates, which represents a key milestone in XTEK’s ballistic armour commercialisation strategy.
commercial order of XTclave™ manufactured ballistic plates, worth >A$1m
Purchase order from CPE
Production Oy, for use by the Finnish Defence Forces, following an extensive
validation and testing process for qualification purposes by the Finnish Army
This order demonstrates
external validation of the quality and demand for XTEK’s state-of-the-art
technology, and places XTEK in a strong position to receive further orders
XTEK Managing Director,
Philippe Odouard, said:
“This purchase order represents a
key milestone for XTEK in the commercialisation of its proprietary XTclave™
technology. The qualification process undertaken, followed by a large order, is
a clear execution of our strategy. We have worked very hard to ensure that the
long customer cycles have progressed in parallel with the construction of the
new manufacturing centre in Adelaide, to ensure that the manufacturing
capability is utilised as soon as possible – and we are now very pleased to see
this strategy successfully executed.”
CPE Production Oy (CPE) is a
supplier of high-performance lightweight ballistic protection solutions to the
Finnish Defence Forces and other European defence customers. In late 2017, XTEK
received a … Read More »
Media Release: Cannatrek Signs Landmark Deal With iX Biopharma’s Subsidiary To Distribute Medicinal Cannabis Via Novel Sublingual Wafer
Australian seed-to-patient medicinal cannabis producer Cannatrek Ltd (“Cannatrek”) announced today it has signed an agreement with iX Syrinx Pty Ltd, a wholly owned subsidiary of Singapore-listed specialty pharmaceutical company iX Biopharma, to distribute sublingual (under the tongue) medicinal cannabis wafers in Australia.
The wafers are formulated
with iX Biopharma’s patented sublingual delivery technology, WaferiX®.
The WaferiX® delivery overcomes three common problems with the delivery of
medicinal cannabis – lack of fixed unit dosages, inconsistent absorption and
variable or poor bioavailability.
In commenting on the
deal, Tommy Huppert, CEO of Cannatrek, said:
“The supply agreement with
iX Syrinx Pty Ltd was a natural progression of Cannatrek’s seed-to-patient
growth plans, which includes the development of different cannabinoid
formulations into active ingredients to treat different diseases and their
symptoms like insomnia, pain and stress.
“We are committed to
providing patients with safe, affordable and effective treatments. Built upon
the novel and patented WaferiX® technology, the unique and superior sublingual
cannabis wafers are well-positioned to disrupt the current market of medicinal
Ms Eva Tan, Director of
Corporate and Commercial Strategy of iX Biopharma said:
“We are excited to partner
with leaders like Cannatrek to reach Australian patients through their
well-established network of prescribers and pharmacies. Patients are now more
knowledgeable about the advantages of sublingually administered cannabis
medicines in increasing bioavailability and improving patient outcomes. … Read More »